NCT04759846 2023-02-21Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF MelanomaPierre Fabre MedicamentPhase 1 Withdrawn
NCT02263898 2020-07-27Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 MutationsJonsson Comprehensive Cancer CenterPhase 2 Withdrawn